DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dopamine (Dopamine Hydrochloride) - Published Studies

 
 



Dopamine Related Published Studies

Well-designed clinical trials related to Dopamine

Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation. [2014]

Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials. [2014]

Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response. [2013]

The role of dopamine in inhibitory control in smokers and non-smokers: a pharmacological fMRI study. [2013]

Effect of low dose dopamine on early graft function in living unrelated kidney donors. [2012]

Efficacy and safety of dopamine agonists in restless legs syndrome. [2012]

Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state. [2012]

Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. [2011.10.18]

Effects of working-memory training on striatal dopamine release. [2011.08.05]

Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome. [2011.07.12]

Renal function after dopamine and fluid administration in patients with malignant obstructive jaundice. A prospective randomized study. [2011.06]

Cardiac valve disease and low-dose dopamine agonist therapy: an artefact of reporting bias? [2011.05]

Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. [2011.05]

The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine. [2011.04.28]

Tinnitus control by dopamine agonist pramipexole in presbycusis patients: a randomized, placebo-controlled, double-blind study. [2011.04]

Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. [2011.04]

Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study. [2011.04]

The role of nutrition in the regulation of luteinizing hormone secretion by the opioidergic, dopaminergic, and serotonergic systems in female Mediterranean goats. [2011.03]

Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words. [2011.02.23]

The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review. [2011.02.12]

Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep. [2011.01]

Dopamine versus norepinephrine in the treatment of shock. [2011]

Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. [2010.12]

Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I. [2010.12]

Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D agonist therapy: part 2. [2010.11]

Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness. [2010.11]

Dopaminergic modulation of the default mode network in Parkinson's disease. [2010.11]

Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation. [2010.10]

Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence. [2010.09.30]

Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease. [2010.09]

Increasing dopamine levels in the brain improves feedback-based procedural learning in healthy participants: an artificial-grammar-learning experiment. [2010.09]

Dopamine precursor depletion improves punishment prediction during reversal learning in healthy females but not males. [2010.08]

Dopamine, paranormal belief, and the detection of meaningful stimuli. [2010.08]

Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. [2010.07.27]

Dopaminergic modulation of rapid reality adaptation in thinking. [2010.05.19]

Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study. [2010.05]

Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. [2010.05]

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease. [2010.04.30]

Dopamine receptor D4 polymorphism predicts the effect of L-DOPA on gambling behavior. [2010.04.15]

Prospective association of dopamine-related polymorphisms with smoking cessation in general care. [2010.04]

The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial. [2010.04]

Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. [2010.04]

Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. [2010.03.10]

Comparison of dopamine and norepinephrine in the treatment of shock. [2010.03.04]

Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. [2010.03]

The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. [2010.03]

Memory encoding and dopamine in the aging brain: a psychopharmacological neuroimaging study. [2010.03]

Dopamine-induced changes in neural network patterns supporting aversive conditioning. [2010.02.08]

Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis. [2010.02]

A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults. [2010.02]

Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. [2010.02]

Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock. [2010.01]

Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease. [2010.01]

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. [2010.01]

Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-beta-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects. [2010]

Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness. [2010]

Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence. [2010]

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease. [2010]

Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. [2010]

Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials. [2010]

Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease. [2010]

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. [2010]

Is dopexamine superior to dopamine in the treatment of multiple trauma patients--a prospective, double-blind, randomised study. [2010]

Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants. [2010]

Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life. [2009.12]

Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. [2009.12]

Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease. [2009.12]

The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study. [2009.11.30]

Absorption, disposition, metabolic fate, and elimination of the dopamine agonist rotigotine in man: administration by intravenous infusion or transdermal delivery. [2009.10]

Decreased ventilatory response to exercise by dopamine-induced inhibition of peripheral chemosensitivity. [2009.09.30]

Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. [2009.09.09]

Dopamine genes and nicotine dependence in treatment-seeking and community smokers. [2009.09]

Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes. [2009.08]

Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function. [2009.07]

Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects. [2009.06]

Striatal dopamine responses to intranasal cocaine self-administration in humans. [2009.05.15]

Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial. [2009.05.01]

Dopamine versus norepinephrine: is one better? [2009.05]

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. [2009.05]

Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. [2009.04]

Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths. [2009.04]

The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. [2009.03]

Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease. [2009.03]

Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. [2009.02.04]

Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine. [2009.02]

Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. [2009.02]

D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. [2009.01]

Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease. [2009]

The effects of withdrawal of dopaminergic medication in nursing home patients with advanced parkinsonism. [2008.11]

Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease. [2008.10]

Defining the boundaries of the response of sleep leg movements to a single dose of dopamine agonist. [2008.09.01]

Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. [2008.09]

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia. [2008.08]

Induction of tolerance of dopaminergic responses in man. [2008.08]

Brain dopamine response in human opioid addiction. [2008.07]

Effects of an attachment-based intervention on daily cortisol moderated by dopamine receptor D4: a randomized control trial on 1- to 3-year-olds screened for externalizing behavior. [2008.06]

A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine. [2008.06]

The role of dopamine in alcohol self-administration in humans: individual differences. [2008.06]

Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. [2008.06]

Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans. [2008.06]

Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. [2008.05]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017